191204 people have viewed this drug in the last 60 days
Updated 2025-06-04
| Last Update | 2023-01-19 |
| Register Year | 2018 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | TOFACITINIB |
| Trade Name | XELJANZ XR 11 mg Extended Release Tablet |
| Strength Unit | mg |
| Pharmaceutical Form | modified-release tablet |
| Administration Route | Oral use |
| Atc Code1 | L04AA29 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Bottle |
| Package Size | 30 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $4646.9 |
| Shelf Life | 48 Months |
| Marketing Company | PFIZER |
| Marketing Country | United States |
| Manufacture Name | PFIZER PHARMACEUTICAL LLC BARCELONETA OPERATIONS |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | ALNAGHI COMPANY |
| Secosnd Agent | Pfizer Saudi Trading |
| Third Agent | |
| Visits | 191204 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| XELJANZ XR 11 mg Extended Release Tablet | $4646.9 | 191204 visits | 2023-01-19 |
| XELJANZ 5 mg film-coated tablet | $4646.9 | 146142 visits | 2023-02-19 |